Exhibit 99.1

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.001 par value per share, of ALX Oncology Holdings, Inc. and further agree to the filing of this agreement as an exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.

 

 

Date: February 14, 2025 TANG CAPITAL PARTNERS, LP  
     
  By:   Tang Capital Management, LLC    
  Its:   General Partner   
     
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Manager   

 

 

TANG CAPITAL PARTNERS III, INC

 
       
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Chief Executive Officer   

 

 

TANG CAPITAL PARTNERS IV, INC

 
       
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Chief Executive Officer   

 

  TANG CAPITAL MANAGEMENT, LLC  
       
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Manager   
     
  /s/ Kevin Tang  
  Name:   Kevin Tang   

 

 

 

 

 

 

ALX Oncology (NASDAQ:ALXO)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 ALX Oncology 차트를 더 보려면 여기를 클릭.
ALX Oncology (NASDAQ:ALXO)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 ALX Oncology 차트를 더 보려면 여기를 클릭.